Company Filing History:
Years Active: 2011
Title: Innovations of Chang In Kim in Cancer Research
Introduction: Chang In Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research through his innovative work on quinazoline derivatives. His research focuses on developing compounds that can inhibit cancer cell growth, which is crucial in the fight against cancer.
Latest Patents: Chang In Kim holds a patent for "Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof." This invention relates to a novel quinazoline derivative and a pharmaceutically acceptable salt that can effectively inhibit the growth of cancer cells. The patent also includes a method for preparing these derivatives and a pharmaceutical composition that comprises them as an active ingredient.
Career Highlights: Chang In Kim is associated with Hanmi Holdings Co., Ltd., a prominent company in the pharmaceutical industry. His work at Hanmi has allowed him to focus on developing innovative solutions for cancer treatment, contributing to the advancement of medical science.
Collaborations: Some of his notable coworkers include Young Jin Ham and Ji Hyeon Gong. Their collaboration has likely enhanced the research and development efforts within their team, leading to impactful innovations in cancer therapies.
Conclusion: Chang In Kim's work exemplifies the importance of innovation in the medical field, particularly in cancer research. His contributions through patents and collaboration with colleagues highlight the ongoing efforts to develop effective treatments for cancer.